Latest Capital Raising News

McLaren Minerals has completed a major drilling phase at its McLaren Titanium Project, uncovering significant extensions to mineralised zones and validating key processing methods. The company also secured $1.28 million in an oversubscribed capital raise to fund next-stage development.

McLaren Minerals reported a net cash outflow in operating and investing activities for Q2 2025 but bolstered its cash reserves with a $1.282 million placement to support advancing feasibility studies.

New Frontier Minerals reports significant heavy rare earth discoveries at Harts Range and promising copper processing results at NWQ, backed by a $1.59 million capital raise.

Panther Metals reports strong gold assay results from stockpiles and fresh nugget discoveries at its Laverton Gold Project, reinforcing its development prospects amid ongoing drilling.

Trinex Minerals has completed a significant capital raise and board restructure during the June 2025 quarter, positioning itself for renewed focus on lithium exploration in Australia and Canada.

Iceni Gold Limited reported its most significant quarter yet at the 14 Mile Well Gold Project, delivering high-grade gold intersections along the Guyer Trend and securing a $2.5 million oversubscribed placement to fund ongoing exploration.

OncoSil Medical has reported a record 20% quarterly increase in dose sales and secured $8.7 million in new capital, underpinning its clinical and commercial expansion in pancreatic cancer treatment.

AuKing Mining Limited has strengthened its financial position with a $5 million loan facility and progressed its strategic Cloncurry Gold Project acquisition, while its Koongie Park JV reports promising scoping study results.

MetalsTech Limited has raised A$3.3 million through strategic placements to fund the advancement of its Sturec Gold Mine Pre-Feasibility Study, which shows strong economic potential with a US$768 million NPV. The company is progressing metallurgical testing and ore sorting technology to enhance project value.

Patrys Limited has completed a modest capital raise and restructured its leadership as it advances its deoxymab antibody program, with a larger entitlement offer announced to fund clinical development and business growth.

Linius Technologies reports a 17.7% rise in quarterly billings, secures a paid proof of concept with a major European football league, and strengthens its board with two new appointments while raising $2.35 million to fuel its SaaS video platform commercialization.

Kore Potash has issued 500 CHESS Depositary Interests (CDIs) at AUD 0.0543 each, with shares set to commence trading on AIM, JSE, and ASX from 1 August 2025. This move finalizes a cleansing prospectus process and updates the company’s total voting rights.